BIOMAT Database Logo BIOMAT Database Logo

[Therapeutic action of a new non-steroid drug (bufexamac) in the treatment of inflammatory dermatologic diseases. Double-blind clinical study]. 1973

A Katsambas, and A Vareltzidis

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003872 Dermatitis Any inflammation of the skin. Dermatitides
D004485 Eczema A dermatitis characterized by a spongiotic tissue reaction pattern occurring as a reaction to many endogenous and exogenous agents. Dermatitis, Eczematous,Eczematous Dermatitis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Katsambas, and A Vareltzidis
["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
October 1980, Minerva medica,
A Katsambas, and A Vareltzidis
Pharmacological and clinical study of a new anti-inflammatory non-steroid topic, Bufexamac.
January 1971, Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde,
A Katsambas, and A Vareltzidis
[Bufexamac, non-steroid anti-inflammatory agent utilizable locally in clinical dermatology].
January 1970, Archives belges de dermatologie et de syphiligraphie,
A Katsambas, and A Vareltzidis
A double-blind clinical study of bufexamac and fluocinolone acetonide in dermatitis.
April 1974, Journal of the Irish Medical Association,
A Katsambas, and A Vareltzidis
Intra-articular treatment of inflammatory arthritis: double-blind trial comparing bufexamac with methylprednisolone acetate.
March 1987, Clinical rheumatology,
A Katsambas, and A Vareltzidis
[Controlled double-blind clinical study of a new rhinologic preparation with mucolytic-anti-inflammatory action].
January 1969, L'Oto-rino-laringologia italiana,
A Katsambas, and A Vareltzidis
Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
February 1970, Current therapeutic research, clinical and experimental,
A Katsambas, and A Vareltzidis
Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
January 1977, Dermatologica,
A Katsambas, and A Vareltzidis
Preliminary double-blind evaluation of a new, non-steroidal anti-inflammatory drug: protacine.
January 1980, Pharmatherapeutica,
A Katsambas, and A Vareltzidis
[Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
January 1981, La Clinica terapeutica,
Copied contents to your clipboard!